Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 110 citing Watts: Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in.... (0.10 sec) 

Sorting out the roles of PPARα in energy metabolism and vascular homeostasis

- nih.gov
P Lefebvre, G Chinetti, JC Fruchart, B … - Journal of Clinical …, 2006 - Am Soc Clin Investig
PPARα is a nuclear receptor that regulates liver and skeletal muscle lipid metabolism as well
as glucose homeostasis. Acting as a molecular sensor of endogenous fatty acids (FAs) and their
derivatives, this ligand-activated transcription factor regulates the expression of genes ...
Cited by 210 - Related articles - BL Direct - All 9 versions

Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds A …

- onlinejacc.org [PDF] 
RS Birjmohun, BA Hutten, JJP Kastelein, ESG … - Journal of the American …, 2005 - Elsevier
Epidemiologic evidence has shown that HDL-C is inversely related to coronary heart disease
(CHD) risk. However, the evidence for reducing CHD risk by raising HDL-C is thin, predominantly
due to the paucity of effective and safe HDL-increasing drugs. ... Randomized controlled ...
Cited by 194 - Related articles - All 14 versions

Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk …

- icor.com.br [PDF] 
JR Crouse III, JS Raichlen, WA Riley, GW Evans, MK … - Jama, 2007 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Context Vasopressin mediates fluid retention in ...
Cited by 107 - Related articles - BL Direct - All 7 versions

Regulation of human ApoA-I by gemfibrozil and fenofibrate through selective …

- ahajournals.org
H Duez, B Lefebvre, P Poulain, IP Torra, F … - … , and vascular biology, 2005 - Am Heart Assoc
From UR.545INSERM, Département d'Athérosclérose (HD, PP, IPT, FP, GL, J.-CF, CF, BS), Institut
Pasteur Lille and Faculté de Pharmacie, Université de Lille2, France; UR.459INSERM, Biologie
Moléculaire des Récepteurs Nucléaires (BL, PL), Faculté de Médecine Lille, France; the ...
Cited by 68 - Related articles - All 8 versions

Low high-density lipoprotein cholesterol: physiological background, clinical …

- nursing2008.com
M Hersberger, A von Eckardstein - Drugs, 2003 - ingentaconnect.com
Abstract. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . 1908 1. Structure of High-Density Lipoprotein (HDL) . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . 1910 1.1 Apolipoproteins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...
Cited by 57 - Related articles - BL Direct - All 6 versions

Dyslipidemia in visceral obesity: mechanisms, implications, and therapy


DC Chan, HPR Barrett, GF Watts - American Journal of …, 2004 - ingentaconnect.com
Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 227 1. Regional Adiposity, Cardiovascular Disease, and
the Metabolic Syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 228 1.1 ...
Cited by 55 - Related articles - BL Direct - All 6 versions

Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed …

- jlr.org
S Bilz, S Wagner, M Schmitz, A Bedynek, U Keller, … - The Journal of Lipid …, 2004 - ASBMB
Kinetics of apo B and apo AI were assessed in 8 patients with mixed hyperlipidemia at baseline
and after 8 weeks of atorvastatin 80 mg qd and micronised fenofibrate 200 mg qd in a cross-over
study. Both increased hepatic production and decreased catabolism of VLDL accounted ...
Cited by 47 - Related articles - BL Direct - All 5 versions

Fenofibrate: metabolic and pleiotropic effects

- bentham.org [PDF] 
V Tsimihodimos, G Miltiadous, SS … - Current Vascular …, 2005 - ingentaconnect.com
Abstract: Disturbances of lipoprotein metabolism represent one of the most important risk factors
for vascular events. However, dyslipidaemic patients often have a number of additional abnormalities
(such as endothelial dysfunction, hypertension, low-grade inflammation, haemostatic ...
Cited by 44 - Related articles - All 5 versions

Review: efficacy and mechanisms of action of statins in the treatment of diabetic …

- endojournals.org
HN Ginsberg - Journal of Clinical Endocrinology & Metabolism, 2006 - Endocrine Soc
Context: The Adult Treatment Panel III recommends 3-hydroxy-3-methylglutaryl coenzyme A
reductase inhibitors, or statins, as first-line lipid-altering therapy for all adult patients with diabetes
mellitus. This is based on the well-characterized efficacy and safety profiles of this class of ...
Cited by 45 - Related articles - BL Direct - All 4 versions

Effects of a potent and selective PPAR-{alpha} agonist in patients with atherogenic …


SE Nissen, SJ Nicholls, K Wolski, DC Howey, E … - Jama, 2007 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Context Fibrates are weak agonists of peroxisome ...
Cited by 43 - Related articles - BL Direct - All 10 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google